Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for May 2009
May 1, 2009
- Allergan Comments on Today's Follow up by the U.S. Food and Drug Administration (FDA) to Its Early Communication, Concluding the Agency's Safety Review of Botulinum Toxins
- SDI Reports: Antiviral Prescriptions Increased Nearly Nine-Fold on Tuesday, April 28
- EMPOWERx E-Prescribing Solution Provides Latest Treatment Guidelines for 2008-2009 H1N1 Influenza Virus
- Allergan Reports First Quarter 2009 Operating Results
- Amylin Sends Letter to Shareholders
May 4, 2009
- FDA, FTC Warn Public of Fraudulent 2009 H1N1 Influenza Products
- New Survey Shows the Difficulty of Developing Effective Flu Vaccines
- Roche Rapidly Responds to WHO Request to Deploy Rapid Response Stockpiles of Tamiflu to Tackle Global Emergence of a New H1N1 Influenza A Strain - Swine Flu
- Ranbaxy Voluntarily Recalls Nitrofurantoin Capsules in the U.S.
- Acadia Pharmaceuticals and Biovail Form Collaboration to Develop and Commercialize Pimavanserin in North America
- SDI Reports: Sixty-Seven Percent Of Physicians Surveyed Have Positive Attitude Toward Electronic Promotional Activities
- Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
- Dr. Freda Lewis-Hall Joins Pfizer As Chief Medical Officer
May 5, 2009
- Teva Reports First Quarter 2009 Results
- Bio-Imaging Technologies to Acquire etrials Worldwide
- Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young
- SDI Reports: amid Swine Flu Fears, New Antiviral Prescriptions Increase over 19 Times in 1 Week
- Sanofi-aventis Converts Its Vitry-sur-Seine Industrial Facility to Biotechnologies
- Health Affairs Thematic Issue On Mental Health Care Explores U.S. Mental Health Care Trends, Comparative Effectiveness, Access For Veterans, And Supported Employment
- MedWatch - Antiepileptic Drugs:FDA Updated Labeling to Warn About Increased Risk of Suicidal Thoughts and Behaviors
- Evotec to Re-engineer Drug Discovery and Development Operations
May 6, 2009
- FDA Issues an Update about Suicidal Behavior and Ideation and Antiepileptic Drugs
- Orion Corporation (FI) - Orion reacquires rights for i.v. levosimendan (Simdax)
- Neurocrine Announces Work Force Restructuring
- GlaxoSmithKline to Divest US Rights for Wellbutrin XL to Biovail for $510 Million
May 7, 2009
- U.S. FDA Licenses Sanofi Pasteur's New Influenza Vaccine Manufacturing Facility
- Proton Pump Inhibitors Interfere With Anti-Clotting Protection of Clopidogrel
- Takeda to Integrate Its Two Manufacturing Operations in Ireland
- Takeda to Start Sales and Marketing Operation in Portugal
- MedWatch - Testosterone gel products: Boxed warning required to inform users of risk of unintended secondary exposure of children to testosterone
- Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
- Exelixis and Boehringer Ingelheim Enter into Collaboration for Development of S1P1 Receptor Agonists in the Field of Autoimmune Diseases
- Statement From Michael Hansen, CEO of Elsevier's Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005
May 8, 2009
- President's FY 2010 Budget for FDA Invests Substantially in Food and Medical Product Safety
- Ardea Biosciences Reports Recent Accomplishments and First Quarter 2009 Financial Results
- European Medicines Agency Recommendations On Extension Of Shelf Life For Tamiflu
May 11, 2009
- SDI Reports: Promotional Expenditures Flatten as the Number of Branded Blockbuster Drugs Decreases
- Warner Chilcott Proposes Redomestication From Bermuda to Ireland
- MedWatch - Tarceva (erlotinib):Dear HCP letter issued to warn about GI perforation, exfoliative skin conditions and corneal perforation/ulceration
- Northfield Effectuates Plant Closing
- King Pharmaceuticals Reports First-Quarter 2009 Financial Results
- Teikoku Pharma USA Acquires Travanti Pharma Inc.
- Vermont Enacts Sweeping Gift Ban; Affects Drug, Device, Biologics Manufacturers
- Regarding the Statement in Pfizer’s 10-Q Report Dated May 8th, 2009
- Merck Statement on California Court Ruling Denying Certification of Class of Plaintiffs Seeking Reimbursement for Vioxx Costs
- PhRMA Statement on Healthcare Reform Coalition
May 12, 2009
- Teijin Pharma Licenses Marketing Rights of TMX-67 in Taiwan to Astellas Pharma Taiwan for Treatment of Hyperuricemia in Patients with Gout
- GSK Extends Strategic Collaboration with Aspen
- Small Promotional Items from Drug Companies May Influence Medical Students' Attitudes
- Roche provides additional donation of 5.65 million packs of Tamiflu to World Health Organization
- Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
- Growth in Drug Sales of the Top 10 Pharmaceutical Companies Slowed to its Lowest Level in Years in 2008
- FDA Sends Warning Letter to General Mills Over Cereal Claims
- Cegedim Dendrite Releases Results of 2009 Direct-to-Consumer Marketing Survey
May 14, 2009
- Most Americans Would Consider Splitting Pills to Save Money If Medicine Remains Safe and Effective, Survey Shows
- Icahn Issues Open Letter to Amylin Shareholders
- FDA Sends Sanofi-Aventis Letter Regarding Taxotere Promotion
May 15, 2009
- GlaxoSmithKline Update: A (H1N1) Influenza Vaccine Development
- President Obama Appoints Dr. Thomas Frieden as CDC Director
- Sanofi-aventis Introduces Sanofi-aventis TV
- Cell Therapeutics Closes Italian Facility, Reduces Headcount and Expects to Cut $14 Million in Operating Expenses
May 18, 2009
- Daiichi Sankyo and MorphoSys Expand Collaboration with Two New Cancer-Related Antibody Programs
- Cimzia(certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease
- Takeda to Acquire IDM Pharma, Adding MEPACT (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
- Watson Provides Update on Ferrlecit Supply and Distribution Agreement
- A Small Number of Bottles of the Antibiotic Rofact (Rifampin) May Contain a Different Drug
- AstraZeneca Announces Toprol-XL (Metoprolol Succinate) is Now Available
May 19, 2009
- U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth
- The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure
- Shire Expands Gastrointestinal Patient Assistance Program for Uninsured or Unemployed Americans
- Onyx Pharmaceuticals Files Complaint Against Bayer Corporation
- "Innovative Medicine Initiative" (IMI): €246 Million to Support Public-Private Research Cooperation for a Fast Development of Better Medicines
- Sebelius Congratulates New FDA Commissioner Peggy Hamburg
May 20, 2009
- Bio-Imaging Technologies Increases Its Offer to Acquire etrials Worldwide
- moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico
- Sandoz to Acquire EBEWE Pharma Specialty Generics Business, Improving Access for Patients Worldwide to Injectable Cancer Drugs
- Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide
- FDA Sends Warning Letter to Cornerstone Therapeutics Regarding Sales Aids
- FDA Sends Warning Letter to Johnson & Johnson Regarding Consumer Webcast Video
- Medication Used to Treat Urination Difficulties for Men Associated With Higher Risk of Ophthalmic Complications Following Cataract Surgery
May 21, 2009
- FDA Updates Information for Tamiflu: Dosing Recommendations for Infants and Technical Documents
- Schering-Plough, Merck Address J&J Remicade Agreement in SEC Filing
- Pharmalive.Com and Mx Magazine Launch New Leadership Report Focusing On The Medical-Technology Industry
May 22, 2009
- Blood Pressure Lowering Drugs Should Not Be Limited to People With High Blood Pressure
- Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
- Dr. Reddy's Receives Approval for Three INDs and Announces Reorganization of Its Drug Discovery Operations
- Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold Following Report of Serious Adverse Event
May 26, 2009
- Daiichi Sankyo and Ranbaxy Announce Reconstitution of Ranbaxy Executive Leadership
- Biogen Idec Sends Letter to Stockholders
May 27, 2009
- Metabasis Therapeutics Announces Corporate Restructuring and Notice of Noncompliance with Nasdaq Listing Requirements
- In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always “Good Medicine”
- New NICE Guideline For Type 2 Diabetes Recognises Benefits From Newer Agents For Blood Glucose Control
- Ignoring Insomnia Costs America $42 Billion a Year
- Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking?
May 28, 2009
- Schering-Plough and Merck Provide Update on Distribution Agreement
- Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for Remicade and Simponi
- CSL Limited Responds to FTC Announcement
- Boehringer Ingelheim helps families hit hardest by economy: national emerging trend study
- Novartis International AG (CH) - Novartis Increases Its Offer Price on Novartis India Ltd.
- FTC Authorizes Suit To Stop CSL’s Proposed $3.1 Billion Acquisition of Talecris Biotherapeutics
- Talecris Responds to U.S. Federal Trade Commission Filing of Complaint to Challenge Proposed CSL Transaction
- Aventis Pharmaceutical to Pay U.S. $95.5 Million to Settle False Claims Act Allegations
- Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists
- Genentech tops MSImage study of oncologists, hemotologists
- PwC Report: Biologics Sector to Drive Biopharma Deal Activity Remainder of 09
- Sanofi-aventis U.S. Announces Settlement of Medicaid 'Best Price' Investigation
May 29, 2009
- A.P. Pharma Announces Additional Restructuring Effort
- CSL reaffirms its commitment to supply Australia with Novel Influenza A (H1N1) ‘Swine Flu’ Vaccine
- FDA MedWatch - Simponi (golimumab)-Risk of Serious Fungal Infections Associated With TNF-álpha Blockers, Including Simponi
- European Medicines Agency Recommends Lifting Of Supply And Treatment Restrictions for Neupro
- Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation
- Mylan Receives Tentative FDA Approval for Generic Version of Singulair
- Dey L.P. to Market EMSAM Skin Patch for Treatment of Major Depressive Disorder
- Sucampo Board of Directors Issues Statement Regarding Sales Performance by Takeda Pharmaceuticals North America for Amitiza
- New Pfizer Data Helps to Identify Kidney Cancer Patients Who May Be Most Likely to Benefit from Treatment
- New Survey Highlights Growing Concern About Risk of Infection in Cancer Patients and Emerging Antibiotic Resistance
- Pfizer's Sutent is Recommended for Reimbursement for Gastrointestinal Stromal Tumor Patients by British Health Agency
- MSL360o Launches LEARN Training Programs and Appoints Dr. Michael T. Cullen as Chief Medical Officer
